Key points from article :
Ani Biome, a company focused on promoting longevity through improved gut health, has received funding from LongeVC, an investment firm specializing in longevity research.
Ani Biome uses machine learning to develop personalized solutions that target inflammation, which is linked to many age-related diseases.
The company has created AgeBiotics, naturally derived molecules tailored to individual needs, to improve gut microbiome function.
Ani Biome's technology includes an app that monitors gut health and uses AI to track emotional state, allowing for highly customized interventions.
Research shows that fermentation-derived nutrients like those used in AgeBiotics offer metabolic and psychological health benefits.
Ani Biome will use the new funding to advance its research, improving the design of its AgeBiotics through advanced machine learning models.
